AAAAAA

   
Results: 1-25 | 26-50 | 51-57
Results: 1-25/57
ADENOSARCOMA OF THE UTERUS FOLLOWING TAMOXIFEN TREATMENT FOR BREAST-CANCER
Authors: MOURITS MJE HOLLEMA H WILLEMSE PHB DEVRIES EGE AALDERS JG VANDERZEE AGJ
Citation: Mje. Mourits et al., ADENOSARCOMA OF THE UTERUS FOLLOWING TAMOXIFEN TREATMENT FOR BREAST-CANCER, International journal of gynecological cancer, 8(2), 1998, pp. 168-171
BIOCHEMICAL PARAMETERS OF BONE METABOLISM IN BONE METASTASES OF SOLIDTUMORS (REVIEW)
Authors: MEIJER WG VANDERVEER E WILLEMSE PHB
Citation: Wg. Meijer et al., BIOCHEMICAL PARAMETERS OF BONE METABOLISM IN BONE METASTASES OF SOLIDTUMORS (REVIEW), Oncology Reports, 5(1), 1998, pp. 5-21
IS OVARIAN-CYST FORMATION RELATED TO TAMOXIFEN USE
Authors: MOURITS MJE DEVRIES EGE WILLEMSE PHB TENHOOR KA HOLLEMA H DEBRUIJN HWA VANDERZEE HWA
Citation: Mje. Mourits et al., IS OVARIAN-CYST FORMATION RELATED TO TAMOXIFEN USE, European journal of cancer, 34, 1998, pp. 21-22
DOSE INTENSITY OF STANDARD ADJUVANT CMF WITH G-CSF FOR PREMENOPAUSAL NODE-POSITIVE BREAST-CANCER PATIENTS
Authors: DEGRAAF H WILLEMSE PHB BONG SB PIERSMA H TJABBES T VANVEELEN H COENEN JLLM DEVRIES EGE
Citation: H. Degraaf et al., DOSE INTENSITY OF STANDARD ADJUVANT CMF WITH G-CSF FOR PREMENOPAUSAL NODE-POSITIVE BREAST-CANCER PATIENTS, European journal of cancer, 34, 1998, pp. 21-21
THE EFFECTIVENESS OF SCREENING ON ORAL OR ENT INFECTION SOURCES IN BREAST-CANCER PATIENTS PRIOR TO PERIPHERAL STEM-CELL TRANSPLANTATION
Authors: VANDERGRAAF WTA ROODENBURG JLN VANDERLAAN BFAM OOSTERHUIS BE SIELING GCM DEVRIES EGE MULDER NH WILLEMSE PHB TENVERGERT EM SLEIJFER DT
Citation: Wta. Vandergraaf et al., THE EFFECTIVENESS OF SCREENING ON ORAL OR ENT INFECTION SOURCES IN BREAST-CANCER PATIENTS PRIOR TO PERIPHERAL STEM-CELL TRANSPLANTATION, Annals of oncology, 9, 1998, pp. 135-135
RANDOMIZED TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-3 VERSUS PLACEBO INPREVENTION OF BONE-MARROW DEPRESSION DURING FIRST-LINE CHEMOTHERAPY FOR OVARIAN-CARCINOMA
Authors: HOFSTRA LS KRISTENSEN GB WILLEMSE PHB VINDEVOGHEL A MEDEN H LAHOUSEN M OBERLING F SORBE B CRUMP M SKLENAR I SLUITER WJ KIESE B TROPE CG DEVRIES EGE
Citation: Ls. Hofstra et al., RANDOMIZED TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-3 VERSUS PLACEBO INPREVENTION OF BONE-MARROW DEPRESSION DURING FIRST-LINE CHEMOTHERAPY FOR OVARIAN-CARCINOMA, Journal of clinical oncology, 16(10), 1998, pp. 3335-3344
TREATMENT OF SPECIAL BREAST-CANCER PATIENTS
Authors: DEGRAAF H WILLEMSE PHB DEVRIES EGE MULDER NH
Citation: H. Degraaf et al., TREATMENT OF SPECIAL BREAST-CANCER PATIENTS, Netherlands journal of medicine, 53(3), 1998, pp. 87-92
ISSUES IN THE CHEMOTHERAPY OF BREAST-CANCER
Authors: DEGRAAF H WILLEMSE PHB DEVRIES EGE MULDER NH
Citation: H. Degraaf et al., ISSUES IN THE CHEMOTHERAPY OF BREAST-CANCER, Netherlands journal of medicine, 53(3), 1998, pp. 97-108
LAPAROSCOPIC PLACEMENT OF PAP CATHETERS FOR INTRAPERITONEAL CHEMOTHERAPY IN OVARIAN-CARCINOMA
Authors: ARTS HJG WILLEMSE PHB TINGA DJ DEVRIES EGE VANDERZEE AGJ
Citation: Hjg. Arts et al., LAPAROSCOPIC PLACEMENT OF PAP CATHETERS FOR INTRAPERITONEAL CHEMOTHERAPY IN OVARIAN-CARCINOMA, Gynecologic oncology, 69(1), 1998, pp. 32-35
A PHASE-II STUDY OF PRIMARY INTRAPERITONEAL PACLITAXEL COMBINED WITH CBDCA CYTOXAN (CC) IN PRIMARY OC/
Authors: WILLEMSE PHB HOFSTRA L BEIJNEN JH DEVRIES EGE VANDERZEE AGJ VANDERGRAAF WTA BOONSTRA H SLEIJFER DT PIERS DA MULDER NH
Citation: Phb. Willemse et al., A PHASE-II STUDY OF PRIMARY INTRAPERITONEAL PACLITAXEL COMBINED WITH CBDCA CYTOXAN (CC) IN PRIMARY OC/, European journal of cancer, 33, 1997, pp. 534-534
REIMBURSEMENT FOR TAXOIDS IN THE NETHERLANDS
Authors: WILLEMSE PHB
Citation: Phb. Willemse, REIMBURSEMENT FOR TAXOIDS IN THE NETHERLANDS, Annals of oncology, 8(9), 1997, pp. 815-815
ATAXIA FOLLOWING DOCETAXEL INFUSION
Authors: HOFSTRA LS VANDERGRAAF WTA DEVRIES EGE HAAXMAREICHE H WILLEMSE PHB
Citation: Ls. Hofstra et al., ATAXIA FOLLOWING DOCETAXEL INFUSION, Annals of oncology, 8(8), 1997, pp. 812-813
OPHTHALMIC TOXICITY FOLLOWING PACLITAXEL INFUSION
Authors: HOFSTRA LS DEVRIES EGE WILLEMSE PHB
Citation: Ls. Hofstra et al., OPHTHALMIC TOXICITY FOLLOWING PACLITAXEL INFUSION, Annals of oncology, 8(10), 1997, pp. 1053-1053
PULMONARY-FUNCTION AFTER HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND RADIOTHERAPY IN PATIENTS WITH ADVANCED LOCO-REGIONAL BREAST-CANCER
Authors: DOLSMA WV DEVRIES EGE VANDERMARK TW SLEIJFER DT WILLEMSE PHB VANDERGRAAF WTA MULDER POM SZABO BG MULDER NH
Citation: Wv. Dolsma et al., PULMONARY-FUNCTION AFTER HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND RADIOTHERAPY IN PATIENTS WITH ADVANCED LOCO-REGIONAL BREAST-CANCER, Anticancer research, 17(1B), 1997, pp. 537-540
HEPATIC-METABOLISM OF PACLITAXEL AND ITS IMPACT IN PATIENTS WITH ALTERED HEPATIC-FUNCTION
Authors: PANDAY VRN HUIZING MT WILLEMSE PHB DEGRAEFF A HUININK WWT VERMORKEN JB BEIJNEN JH
Citation: Vrn. Panday et al., HEPATIC-METABOLISM OF PACLITAXEL AND ITS IMPACT IN PATIENTS WITH ALTERED HEPATIC-FUNCTION, Seminars in oncology, 24(4), 1997, pp. 34-38
EFFECT OF LOW-DOSE ORAL ETOPOSIDE ON SERUM CA-125 IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN-CANCER
Authors: DEJONG RS HOFSTRA LS WILLEMSE PHB DEBRUIJN HWA DEVRIES EGE BOONSTRA H MULDER NH
Citation: Rs. Dejong et al., EFFECT OF LOW-DOSE ORAL ETOPOSIDE ON SERUM CA-125 IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN-CANCER, Gynecologic oncology, 66(2), 1997, pp. 197-201
CARDIOTOXICITY FROM INTENSIVE CHEMOTHERAPY COMBINED WITH RADIOTHERAPYIN BREAST-CANCER
Authors: DEGRAAF H DOLSMA WV WILLEMSE PHB VANDERGRAAF WTA SLEIJFER DT DEVRIES EGE MULDER NH
Citation: H. Degraaf et al., CARDIOTOXICITY FROM INTENSIVE CHEMOTHERAPY COMBINED WITH RADIOTHERAPYIN BREAST-CANCER, British Journal of Cancer, 76(7), 1997, pp. 943-945
PACLITAXEL, IFOSFAMIDE AND CISPLATIN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR OR RECOMBINANT HUMAN INTERLEUKIN-3 AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN OVARIAN-CANCER - A FEASIBILITY STUDY
Authors: VELDHUIS GJ WILLEMSE PHB BEIJNEN JH BOONSTRA H PIERSMA H VANDERGRAAF WTA DEVRIES EGE
Citation: Gj. Veldhuis et al., PACLITAXEL, IFOSFAMIDE AND CISPLATIN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR OR RECOMBINANT HUMAN INTERLEUKIN-3 AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN OVARIAN-CANCER - A FEASIBILITY STUDY, British Journal of Cancer, 75(5), 1997, pp. 703-709
RANDOMIZED COMPARISON OF ETOPOSIDE PHARMACOKINETICS AFTER ORAL ETOPOSIDE PHOSPHATE AND ORAL ETOPOSIDE
Authors: DEJONG RS MULDER NH UGES DRA KAUL S WINOGRAD B SLEIJFER DT GROEN HJM WILLEMSE PHB VANDERGRAAF WTA DEVRIES EGE
Citation: Rs. Dejong et al., RANDOMIZED COMPARISON OF ETOPOSIDE PHARMACOKINETICS AFTER ORAL ETOPOSIDE PHOSPHATE AND ORAL ETOPOSIDE, British Journal of Cancer, 75(11), 1997, pp. 1660-1666
RAISED SERUM SQUAMOUS-CELL CARCINOMA ANTIGEN LEVELS IN MALIGNANT TRANSFORMATION OF MATURE CYSTIC OVARIAN TERATOMA
Authors: DEBRUIJN HWA HOLLEMA H WILLEMSE PHB TENHOOR KA BOONSTRA H
Citation: Hwa. Debruijn et al., RAISED SERUM SQUAMOUS-CELL CARCINOMA ANTIGEN LEVELS IN MALIGNANT TRANSFORMATION OF MATURE CYSTIC OVARIAN TERATOMA, International journal of gynecological cancer, 6(1), 1996, pp. 76-79
POTENTIAL USE OF RECOMBINANT HUMAN INTERLEUKIN-6 IN CLINICAL ONCOLOGY
Authors: VELDHUIS GJ WILLEMSE PHB MULDER NH LIMBURG PC DEVRIES EGE
Citation: Gj. Veldhuis et al., POTENTIAL USE OF RECOMBINANT HUMAN INTERLEUKIN-6 IN CLINICAL ONCOLOGY, Leukemia & lymphoma, 20(5-6), 1996, pp. 373
OPTIMIZATION OF A CLASSICAL AROMATASE-ACTIVITY ASSAY AND APPLICATION IN NORMAL, ADENOMATOUS AND MALIGNANT BREAST PARENCHYMA
Authors: DIKKESCHEI LD WOLTHERS BG BOSZUUR I DELARIVIERE GB NAGEL GT VANDERKOLK DA WILLEMSE PHB
Citation: Ld. Dikkeschei et al., OPTIMIZATION OF A CLASSICAL AROMATASE-ACTIVITY ASSAY AND APPLICATION IN NORMAL, ADENOMATOUS AND MALIGNANT BREAST PARENCHYMA, Journal of steroid biochemistry and molecular biology, 59(3-4), 1996, pp. 305-313
CONCURRENT CHEMOTHERAPY AND RADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED-CARCINOMA OF THE CERVIX
Authors: PRAS E WILLEMSE PHB BOONSTRA H HOLLEMA H HEESTERS MAAM SZABO BG DEBRUIJN HWA AALDERS JG DEVRIES EGE
Citation: E. Pras et al., CONCURRENT CHEMOTHERAPY AND RADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED-CARCINOMA OF THE CERVIX, Annals of oncology, 7(5), 1996, pp. 511-516
DOSE INTENSITY OF STANDARD ADJUVANT CMF WITH GRANULOCYTE-COLONY-STIMULATING FACTOR FOR PREMENOPAUSAL PATIENTS WITH NODE-POSITIVE BREAST-CANCER
Authors: DEGRAAF H WILLEMSE PHB BONG SB PIERSMA H TJABBES T VANVEELEN H COENEN JLLM DEVRIES EGE
Citation: H. Degraaf et al., DOSE INTENSITY OF STANDARD ADJUVANT CMF WITH GRANULOCYTE-COLONY-STIMULATING FACTOR FOR PREMENOPAUSAL PATIENTS WITH NODE-POSITIVE BREAST-CANCER, Oncology, 53(4), 1996, pp. 289-294
TREATMENT OF ADVANCED SEMINOMA WITH CYCLOPHOSPHAMIDE, VINCRISTINE ANDCARBOPLATIN ON AN OUTPATIENT BASIS
Authors: SLEIJFER S WILLEMSE PHB DEVRIES EGE VANDERGRAAF WTA KOOPS HS MULDER NH
Citation: S. Sleijfer et al., TREATMENT OF ADVANCED SEMINOMA WITH CYCLOPHOSPHAMIDE, VINCRISTINE ANDCARBOPLATIN ON AN OUTPATIENT BASIS, British Journal of Cancer, 74(6), 1996, pp. 947-950
Risultati: 1-25 | 26-50 | 51-57